Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785848 · ClinicalTrials.gov registry record
Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging
A clinical trial of Sickle Cell Disease, sponsored by Vanderbilt University.
- Active
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT02785848 is a study of Sickle Cell Disease that is active but no longer recruiting, run by Vanderbilt University. The registered enrollment target is 70 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02785848, a study of Sickle Cell Disease, is active but no longer recruiting, sponsored by Vanderbilt University.
- ACTIVE NOT RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.
Conditions Studied
Interventions
- OTHER Interviews and Surveys
Study Locations (1)
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-05 |
| Est. Completion | 2028-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02785848
The ClinicalTrials.gov registry entry for NCT02785848 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (76% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Interviews and Surveys is the first listed.
NCT02785848 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02785848 about?
NCT02785848 is a clinical study titled "Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging". The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in ...
What is the current status of trial NCT02785848?
This trial is currently active not recruiting. The enrollment target is 70 participants. The study started on 2016-05. Estimated completion is 2028-07.
What conditions does trial NCT02785848 study?
This clinical trial studies the following conditions: Sickle Cell Disease.
What interventions are being tested in trial NCT02785848?
The interventions under investigation include: Interviews and Surveys (OTHER).
Who is sponsoring clinical trial NCT02785848?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02785848 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RECRUITING · Phase 2
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RECRUITING · Phase 1
-
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.